AJP - Regulatory, Integrative and Comparative Physiology, Vol 265, Issue 3 659-R669, Copyright © 1993 by American Physiological Society

ARTICLES

Modulation of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and beta-adrenergic agonists

M. H. Huang, F. M. Smith and J. A. Armour
Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scota, Canada.

To investigate whether microvolumes (< or = 10 microliters) of nicotinic, muscarinic, and beta-adrenergic agonists can modify intrinsic cardiac neuronal activity, nicotine, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), bethanechol chloride, and isoproterenol were separately administered adjacent to spontaneously active in situ epicardial neurons in 15 anesthetized dogs. Neuronal activity generated by 46 of 63 neurons was modified by these neurochemicals, with about half of the neurons affected by more than one agent. In association with these neuronal responses, cardiodynamic responses were elicited in 17 instances. When cardiac augmentation was elicited, it persisted after the administration of atropine but not of timolol. After cardiac decentralization, 40% of previously active neurons were still modified by local application of chemicals; cardiodynamic responses were elicited in nine instances. The activity of six units was modified by isoproterenol after subsequent administration of hexamethonium. These data confirm that intrinsic cardiac neurons possess nicotinic and muscarinic receptors and demonstrate that some intrinsic cardiac neurons also possess beta-adrenergic receptors. Furthermore, these data demonstrate that intrinsic cardiac neurons with nicotinic, muscarinic, and beta-adrenergic receptors are involved in cardiac regulation.

This article has been cited by other articles:

				M. Waldmann, G. W. Thompson, G. C. Kember, J. L. Ardell, and J. A. Armour Stochastic behavior of atrial and ventricular intrinsic cardiac neurons J Appl Physiol, August 1, 2006; 101(2): 413 - 419. [Abstract] [Full Text] [PDF]

				R. C. Arora, R. Cardinal, F. M. Smith, J. L. Ardell, L. J. Dell'Italia, and J. A. Armour Intrinsic cardiac nervous system in tachycardia induced heart failure Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1212 - R1223. [Abstract] [Full Text] [PDF]

				G. P. Walcott, S. B. Melnick, C. R. Killingsworth, W. M. Smith, and R. E. Ideker Effects of burst stimulation during ventricular fibrillation on cardiac function after defibrillation Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H766 - H774. [Abstract] [Full Text] [PDF]

				F. M. Smith, A. S. McGuirt, J. Leger, J. A. Armour, and J. L. Ardell Effects of chronic cardiac decentralization on functional properties of canine intracardiac neurons in vitro Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1474 - R1482. [Abstract] [Full Text] [PDF]

				D. M. Kaye, L. Johnston, G. Vaddadi, H. Brunner-LaRocca, G. L. Jennings, and M. D. Esler Mechanisms of Carvedilol Action in Human Congestive Heart Failure Hypertension, May 1, 2001; 37(5): 1216 - 1221. [Abstract] [Full Text] [PDF]

				E. R. Azevedo and J. D. Parker Parasympathetic Control of Cardiac Sympathetic Activity : Normal Ventricular Function Versus Congestive Heart Failure Circulation, July 20, 1999; 100(3): 274 - 279. [Abstract] [Full Text] [PDF]

				G. E. Newton, E. R. Azevedo, and J. D. Parker Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study Circulation, May 11, 1999; 99(18): 2402 - 2407. [Abstract] [Full Text] [PDF]

				F. M. Smith Extrinsic inputs to intrinsic neurons in the porcine heart in vitro Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1999; 276(2): R455 - R467. [Abstract] [Full Text] [PDF]

				G. E. Newton and J. D. Parker Acute Effects of ß1-Selective and Nonselective ß-Adrenergic Receptor Blockade on Cardiac Sympathetic Activity in Congestive Heart Failure Circulation, August 1, 1996; 94(3): 353 - 358. [Abstract] [Full Text]